Sunday 31 January 2016
  • :
  • :

Volume Active Movements- Amgen, (NASDAQ:AMGN), TJX Companies (NYSE:TJX), Humana (NYSE:HUM), Graphic Packaging Holding Company (NYSE:GPK)

On Tuesday, Amgen, Inc. (NASDAQ:AMGN)’s shares declined -0.38% to $156.44.

Amgen, Inc. (AMGN) declared a partnershipwith Roche on a Phase 1b study to evaluate the safety and efficacy of talimogene laherparepvec, Amgen’s investigational oncolytic immunotherapy, in combination with Roche’s investigational anti-PDL1 therapy, atezolizumab (also known as MPDL3280A), in patients with triple-negative breast cancer and colorectal cancer with liver metastases.

Talimogene laherparepvec is an investigational oncolytic immunotherapy designed to selectively replicate in tumors (but not normal tissue) and to initiate an immune response to target cancer cells. Atezolizumab is an investigational monoclonal antibody designed to interfere with the PD-L1 protein.

The rationale for combining these two investigational agents is to activate an anti-tumor immune response with talimogene laherparepvec and to block inhibitory T cell checkpoints with atezolizumab, to potentially enhance the anti-tumor activity relative to each agent alone.

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.

TJX Companies Inc (NYSE:TJX)’s shares dropped -0.31% to $64.89.

TJX Companies Inc (TJX) declared sales and earnings results for the first quarter ended May 2, 2015. Net sales for the first quarter of Fiscal 2016 raised 6% to $6.9 billion, and merged comparable store sales raised 5%. Net income for the first quarter was $475 million, and diluted earnings per share were $.69, an 8% enhance over the prior year.

Carol Meyrowitz, Chief Executive Officer of The TJX Companies, Inc., stated, “We are extremely happy with our continued momentum and first quarter performance. Our 5% merged comparable store sales growth and 8% enhance in earnings per share were both well above our plan. Our outstanding values and exciting mix of apparel and home fashions continue to resonate with shoppers across all of our geographies. It was great to see that, similar to last quarter, comp sales were almost entirely driven by customer traffic and we had a noteworthyenhance in units sold. At the same time, we also saw a strong enhance in our merchandise margins. We were very happy that we achieved these strong results despite noteworthyforeign currency headwinds and while simultaneously investing in our business to support our growth aims. Our underlying business remains strong, our values are better than ever, and we have many exciting initiatives planned for the remainder of the year to continue driving sales and customer traffic. Further, we are thrilled to see our retail brands becoming more powerful and recognizable with consumers. We are raising our full year earnings per share and comp sales guidance based on the strength of our first quarter results. The second quarter is off to a very strong start and we are confident in our ability to achieve our plans for 2015. We remain convinced that we have the right strategy in place to achieve our long-term growth aims as TJX continues on the path to becoming a $40 billion-plus global, value retailer!”

The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. It operates through four segments: Marmaxx, HomeGoods, TJX Canada, and TJX Europe. The company sells family apparel, counting footwear and accessories; home fashions, such as home basics, accent furniture, lamps, rugs, wall décor, decorative accessories, and giftware; and other merchandise. It operates stores under the T.J. Maxx, Marshalls, HomeGoods, Winners, HomeSense, T.K. Maxx, and Sierra Trading Post names, in addition to operates e-commerce sites,, and

At the end of Tuesday’s trade, Humana Inc (NYSE:HUM)‘s shares dipped -0.08% to $214.74.

Humana Inc (HUM) declared recently that it has accomplished its formerly declared sale of the stock of its wholly-owned partner, Concentra Inc. (Concentra), to MJ Acquisition Corporation for about $1.055 billion in cash, subject to customary adjustments. MJ Acquisition Corporation is a joint venture between Select Medical Holdings Corporation (SEM), a leading operator of specialty hospitals and outpatient rehabilitation clinics in the U.S., and Welsh, Carson, Anderson & Stowe XII, L.P., a private equity fund.

The divestiture of Concentra demonstrates the company’s commitment to its formerly declared business portfolio review, ensuring each business supports the company’s integrated care delivery strategy and earns the appropriate return on invested capital.

As formerly revealed, Humana anticipates recognition of a one-time gain from the sale of Concentra during the year ending December 31, 2015 in the range of $1.35 to $1.45 per share, counting the $0.35 per share tax benefit recognized in the quarter ended March 31, 2015 related to the then pending sale.

Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Employer Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.

Graphic Packaging Holding Company (NYSE:GPK), ended its Tuesday’s trading session with 0.49% gain , and closed at $14.33.

Graphic Packaging Holding Company (GPK) Board of Directors declared a quarterly dividend of $0.05 per share. The dividend is payable on July 5, 2015 to shareholders of record at the close of business on June 15, 2015.

Graphic Packaging Holding Company, together with its auxiliaries, provides paper-based packaging solutions to food, beverage, and other consumer products companies. The company produces a range of paperboard grades convertible into folding cartons primarily to protect products, such as food, detergents, paper products, beverages, and health and beauty aids. It also designs, manufactures, and installs packaging machinery related to the assembly of cartons; and produces and sells corrugated medium and kraft papers.


This article is published by The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.